Vagal cardiac activity in essential hypertension: the effects of metoprolol and ramipril

American Journal of Hypertension
R K VesalainenT J Kaila

Abstract

Cardiovascular parasympathetic activity is attenuated in essential hypertension. Both beta-adrenoceptor antagonists and angiotensin converting enzyme inhibitors have been reported to increase vagal modulation of heart rate and baroreflex sensitivity, but the relations between the antihypertensive and vagal cardiac effects of these drugs have remained unclear in essential hypertension. In the present study we evaluated the effects of a 4-week crossover monotherapy with metoprolol and ramipril on spectrum analysis indices of heart rate variability in the supine rest and head-up tilted positions, baroreflex sensitivity (phenylephrine method), and 24-h ambulatory blood pressure (BP) in 12 formerly untreated stage 1-2 essential hypertensive patients. Compared to the pretreatment values, both drugs decreased BP similarly and significantly. However, the drugs showed different effects on cardiac vagal activity: metoprolol increased significantly mean R-R interval, R-R interval total, and high-frequency variability at supine rest and baroreflex sensitivity, but ramipril did not significantly affect these variables. The metoprolol-induced decrease in ambulatory BP correlated with the prolongation of the R-R interval and the increase of h...Continue Reading

Citations

Dec 22, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·C J ThomasR L Woods
Jun 27, 2007·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Matthias Weck
Nov 22, 2007·Journal of Cardiovascular Pharmacology·Sara Del ColleFranco Veglio
Mar 17, 2010·American Journal of Physiology. Heart and Circulatory Physiology·P Y W SinY C Tzeng
May 18, 2001·American Journal of Physiology. Heart and Circulatory Physiology·J A TaylorD L Eckberg
Mar 29, 2001·Clinical and Experimental Hypertension : CHE·F RabbiaF Veglio
Nov 5, 2003·Journal of Hypertension·Christina AbrahamssonLars Lind
Aug 11, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Emanuel Zitt, Alexander R Rosenkranz
Jun 16, 2018·Clinical Science·Alynne Carvalho-GalvãoMaria do Socorro de França-Silva
Oct 31, 2020·Cardiovascular Therapeutics·Małgorzata MaciorowskaGrzegorz Gielerak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.